The real problem holding back connected vehicle programmes

Tern plc

Automakers are pushing hard to deliver software-defined vehicles with full over-the-air functionality. But many programmes are hitting delays and complications that have little to do with software quality or hardware design. The problem is identity, specifically, how manufacturers handle cryptographic keys, certificates, and trust across every electronic component and software process in the vehicle.

This used to be a security issue. Now, it is a production and operations issue, directly affecting rollout speed, servicing, and regulatory compliance. As vehicles become more connected and updates more frequent, identity management is turning into a core constraint that affects timelines and scale. Automotive platforms are struggling to keep cryptographic assets consistent across multiple suppliers, regions, and ECU generations. That inconsistency can block updates, break rollback mechanisms, and prevent legitimate servicing.

The UN’s WP.29 cybersecurity requirements, together with ISO 21434 and upcoming legislation like the EU Cyber Resilience Act, are putting formal pressure on OEMs to prove their vehicles are secure, traceable, and tamper-proof throughout their lifetime. Even authorised servicing now demands stricter identity and access control, forcing manufacturers to rework how they handle keys and certificates from factory to workshop.

Device Authority is one such company helping OEMs manage identity at scale. Its platform supports automated certificate provisioning, policy enforcement, and compliance tracking across ECUs, software components and servicing tools.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Search